{"name":"Koen van Besien","slug":"koen-van-besien","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Evomela","genericName":"Evomela","slug":"evomela","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Evomela","genericName":"Evomela","slug":"evomela","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNZ29WeF8zMVVmRHFyZzg0T0tQR2RTSnBtSEluVEs1V3pqTWU0amZZNFBjRzl3cWswNVlfYVFtOVBTR0xia0FGT1EtTkNzeHdhd1RvbGZva2VwN2xMUTlyd2JiSkV5aGFDb1BYYlV2eTZwcV9PYjlQcFUxbjJveklKQm9VQWI3OUpHNXhCNDZVVkhVWXZsbS1yZjN6WFFSNDRBRVcxNXJrMGpYUEcwQjZIMTJXRFdrbVNpSHBGZU81N0xRZw?oc=5","date":"2026-04-07","type":"pipeline","source":"London South East","summary":"Hemogenyx Pharmaceuticals Share News (HEMO) - London South East","headline":"Hemogenyx Pharmaceuticals Share News (HEMO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBGTnhRYjkyQTY5Yjc5SFNPTmlLMU12YmdTS3dXTXZwbjNnazVhUWk5UnZsZlpCSkQ0Uk03NFV2ZktBX19HRjBrOElGSUVscHU0UV93bk1OOEx5ZTRRZG1n?oc=5","date":"2024-02-06","type":"trial","source":"nature.com","summary":"A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome - nature.com","headline":"A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress synd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNR1JCcFQ2cGZtNG8xaTBQM0pJZDM2ZHNNZ3ZSTTJVeUVxd3B1X1JrMy1ZdU5QaFBPbUc5TUJsd2R4VnBhNkVtbktUSmU5cXJsdXAtVS1CTW43MTVUNzZ2NldMQlQzMlFDT1FySlJOR1k2SHIza2czNW5kQ0lVT2lVRUY2b1VuczVpSmJJdk43aDNPZm5nbkhteC1CNGQ3Q3hJeGRRcmtOVFUxWVVWYUxZTEY4RTRHZ3hDMnJ4LVRqdU9NNzBjMmlOb0xKWEtDZEdMbXdvVm9OcUFXTUNPd0E1azc1dklfdw?oc=5","date":"2023-02-03","type":"pipeline","source":"WKYC","summary":"A look inside the lab where medical miracles are made at University Hospitals Cleveland Medical Center - WKYC","headline":"A look inside the lab where medical miracles are made at University Hospitals Cleveland Medical Center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQbmFJb3Utd1Z4QzZlb0kza0o2SEdqbzdPTkxWOENtcEdvNm5jcnBNNzg0UTlnZjNfdmdieVVTbEtVeDVwclhXdEowTExzNlkzMVVYa0RYNEFXelBtSGZhd0hQV1Z1UzhUR2VsYU1nemlpSjFjc19LNk5sVXNCd0Q1a09BR244XzZrNkxrOFdXRURWSHp1dXpyb3J3?oc=5","date":"2019-09-18","type":"pipeline","source":"Health Matters | NYP","summary":"CAR T-Cell Therapy, a Breakthrough Treatment for Cancer Patients - Health Matters | NYP","headline":"CAR T-Cell Therapy, a Breakthrough Treatment for Cancer Patients - Health Matters | NYP","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}